Six-month interim results from the first clinical study on the Zenapro® Hybrid Hernia Repair Device were released at SAGES 2016 in Boston.1
This is the first clinical study on the use of a hybrid hernia-repair device in humans. This study follows 63 patients who have had a ventral hernia-repair procedure using Zenapro devices.
The patients have an average BMI of 34.5 ± 7.8. A majority of these patients also have comorbidities such as a smoking history, hypertension, and previous abdominal surgeries. The clinical study will conclude after 12 months of following-up with patients.
According to the study’s authors, these interim results show an acceptable recurrence and complication rate.
Watch videos of ventral hernia-repair procedures at zenapro.cookmedical.com.
- El-Hayek K, Yoo K, Phillips M, et al. First human experience with a hybrid biologic and synthetic mesh: ZenaproTM Hernia Repair Device for Ventral Hernia Repair. Poster presentation at: 2016 Society of American Gastrointestinal and Endoscopic Surgeons Conference; March 16-19; Boston, Massachusetts.